BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

737 related articles for article (PubMed ID: 31570536)

  • 21. Δ9-Tetrahydrocannabinol alone and combined with cannabidiol mitigate fear memory through reconsolidation disruption.
    Stern CA; Gazarini L; Vanvossen AC; Zuardi AW; Galve-Roperh I; Guimaraes FS; Takahashi RN; Bertoglio LJ
    Eur Neuropsychopharmacol; 2015 Jun; 25(6):958-65. PubMed ID: 25799920
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of Tetrahydrocannabinol and Cannabidiol on Brain-Derived Neurotrophic Factor and Tropomyosin Receptor Kinase B Expression in the Adolescent Hippocampus.
    Winstone J; Shafique H; Clemmer ME; Mackie K; Wager-Miller J
    Cannabis Cannabinoid Res; 2023 Aug; 8(4):612-622. PubMed ID: 35639364
    [No Abstract]   [Full Text] [Related]  

  • 23. Beta-endorphin elevations in the ventral tegmental area regulate the discriminative effects of Delta-9-tetrahydrocannabinol.
    Solinas M; Zangen A; Thiriet N; Goldberg SR
    Eur J Neurosci; 2004 Jun; 19(12):3183-92. PubMed ID: 15217374
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An assessment of concurrent cannabidiol and Δ⁹-tetrahydrocannabinol administration in place aversion and taste avoidance conditioning.
    Hempel BJ; Clasen MM; Nelson KH; Woloshchuk CJ; Riley AL
    Exp Clin Psychopharmacol; 2018 Apr; 26(2):205-213. PubMed ID: 29648861
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neural correlates of interactions between cannabidiol and Δ(9) -tetrahydrocannabinol in mice: implications for medical cannabis.
    Todd SM; Arnold JC
    Br J Pharmacol; 2016 Jan; 173(1):53-65. PubMed ID: 26377899
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Distinct effects of {delta}9-tetrahydrocannabinol and cannabidiol on neural activation during emotional processing.
    Fusar-Poli P; Crippa JA; Bhattacharyya S; Borgwardt SJ; Allen P; Martin-Santos R; Seal M; Surguladze SA; O'Carrol C; Atakan Z; Zuardi AW; McGuire PK
    Arch Gen Psychiatry; 2009 Jan; 66(1):95-105. PubMed ID: 19124693
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of cannabidiol and Δ
    Smith SA; Le GH; Teopiz KM; Kwan ATH; Rhee TG; Ho RC; Wu J; Cao B; Ceban F; McIntyre RS
    Drug Metab Rev; 2024; 56(2):164-174. PubMed ID: 38655747
    [TBL] [Abstract][Full Text] [Related]  

  • 28. How does cannabidiol (CBD) influence the acute effects of delta-9-tetrahydrocannabinol (THC) in humans? A systematic review.
    Freeman AM; Petrilli K; Lees R; Hindocha C; Mokrysz C; Curran HV; Saunders R; Freeman TP
    Neurosci Biobehav Rev; 2019 Dec; 107():696-712. PubMed ID: 31580839
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Individual and combined effects of acute delta-9-tetrahydrocannabinol and cannabidiol on psychotomimetic symptoms and memory function.
    Morgan CJA; Freeman TP; Hindocha C; Schafer G; Gardner C; Curran HV
    Transl Psychiatry; 2018 Sep; 8(1):181. PubMed ID: 30185793
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Using the BMD Approach to Derive Acceptable Daily Intakes of Cannabidiol (CBD) and Tetrahydrocannabinol (THC) Relevant to Electronic Cigarette Liquids.
    Hindelang P; Scharinger A; Richling E; Walch SG; Lachenmeier DW
    Front Biosci (Landmark Ed); 2022 Jul; 27(8):228. PubMed ID: 36042166
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dissociable effects of cannabis with and without cannabidiol on the human brain's resting-state functional connectivity.
    Wall MB; Pope R; Freeman TP; Kowalczyk OS; Demetriou L; Mokrysz C; Hindocha C; Lawn W; Bloomfield MA; Freeman AM; Feilding A; Nutt D; Curran HV
    J Psychopharmacol; 2019 Jul; 33(7):822-830. PubMed ID: 31013455
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Opposite effects of delta-9-tetrahydrocannabinol and cannabidiol on human brain function and psychopathology.
    Bhattacharyya S; Morrison PD; Fusar-Poli P; Martin-Santos R; Borgwardt S; Winton-Brown T; Nosarti C; O' Carroll CM; Seal M; Allen P; Mehta MA; Stone JM; Tunstall N; Giampietro V; Kapur S; Murray RM; Zuardi AW; Crippa JA; Atakan Z; McGuire PK
    Neuropsychopharmacology; 2010 Feb; 35(3):764-74. PubMed ID: 19924114
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuronal and molecular effects of cannabidiol on the mesolimbic dopamine system: Implications for novel schizophrenia treatments.
    Renard J; Norris C; Rushlow W; Laviolette SR
    Neurosci Biobehav Rev; 2017 Apr; 75():157-165. PubMed ID: 28185872
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of low doses of delta9-tetrahydrocannabinol and cannabidiol on the extinction of cocaine-induced and amphetamine-induced conditioned place preference learning in rats.
    Parker LA; Burton P; Sorge RE; Yakiwchuk C; Mechoulam R
    Psychopharmacology (Berl); 2004 Sep; 175(3):360-6. PubMed ID: 15138755
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cannabinoids, reward processing, and psychosis.
    Gunasekera B; Diederen K; Bhattacharyya S
    Psychopharmacology (Berl); 2022 May; 239(5):1157-1177. PubMed ID: 33644820
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A randomised controlled trial of vaporised Δ
    Solowij N; Broyd S; Greenwood LM; van Hell H; Martelozzo D; Rueb K; Todd J; Liu Z; Galettis P; Martin J; Murray R; Jones A; Michie PT; Croft R
    Eur Arch Psychiatry Clin Neurosci; 2019 Feb; 269(1):17-35. PubMed ID: 30661105
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuroprotective Effects of Cannabidiol but Not Δ
    Landucci E; Mazzantini C; Lana D; Davolio PL; Giovannini MG; Pellegrini-Giampietro DE
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34575932
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Heterogeneity in the composition of marijuana seized in California.
    Burgdorf JR; Kilmer B; Pacula RL
    Drug Alcohol Depend; 2011 Aug; 117(1):59-61. PubMed ID: 21288662
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cannabidiol potentiates pharmacological effects of Delta(9)-tetrahydrocannabinol via CB(1) receptor-dependent mechanism.
    Hayakawa K; Mishima K; Hazekawa M; Sano K; Irie K; Orito K; Egawa T; Kitamura Y; Uchida N; Nishimura R; Egashira N; Iwasaki K; Fujiwara M
    Brain Res; 2008 Jan; 1188():157-64. PubMed ID: 18021759
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Drug-drug interactions as a result of co-administering Δ
    Rong C; Carmona NE; Lee YL; Ragguett RM; Pan Z; Rosenblat JD; Subramaniapillai M; Shekotikhina M; Almatham F; Alageel A; Mansur R; Ho RC; McIntyre RS
    Expert Opin Drug Saf; 2018 Jan; 17(1):51-54. PubMed ID: 29082802
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 37.